Ipsen Biopharmaceuticals, Inc.

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. At Ipsen, we develop
and commercialize medicines in three key therapeutic areas Oncology, Neuroscience and Rare Disease. We
work to provide hope for patients whose lives are challenged by difficult to treat diseases, including rare
diseases such as acromegaly and certain growth disorders. The patients we serve live with rare and debilitating
diseases, and we pride ourselves on putting these patients first. We are always ready to listen to and learn
from patients. Every day, our more than 5,700 employees worldwide, including over 600 in North America,
work diligently to improve the lives of patients around the world. For more information please visit
www.ipsenus.com